Sign in
4

Changes in Ownership

OCULAR THERAPEUTIX, INC Filed Acc 0001104659-25-084117

Chief Development Officer sold 3,011 shares at $12.04 ($36,252)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Kaiser Peter · Chief Development Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-08-25 Sale : show line 1 in the form 10b5-1 −3,011 $12.04 $36,252 204,093 D
Open-market sales · 3,011 sh · avg $12.04 · $36,252
Loading xslF345X05/tm2524438-4_4seq1.xml…